BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

pfizer back in town - tacere last paper, page-7

  1. J8
    14,532 Posts.
    lightbulb Created with Sketch. 821
    clock Created with Sketch.
    05/02/14
    20:51
    Post #: 12897759
    I wonder when the paper was actually written.

    "The paper was authored by Benitec’s Senior Vice President of R&D, Dr David Suhy, along with several research scientists from Pfizer. This work was a result of the collaboration between Tacere Therapeutics (acquired by Benitec in October 2012) and Pfizer."


    Pfizer were at the RAC meeting.
    BLT Price at posting: 84.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.